The Justice Department alleged that Mallinckrodt ARD LLC, started calculating and paying rebates as if Acthar was a new drug first marketed in 2013 after the Food and Drug Administration approved a new indication for its use in 2010. "U.S. Sues Mallinckrodt for Allegedly Underpaying Medicaid Rebates," on March 3, 2020, incorrectly referred to the agency as the federal drug administration.

(END) Dow Jones Newswires

June 14, 2021 14:26 ET (18:26 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Grafico Azioni Mallinckrodt () (USOTC:MNKKQ)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Mallinckrodt ()
Grafico Azioni Mallinckrodt () (USOTC:MNKKQ)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Mallinckrodt ()